DYN FY 2024 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$344M

Net Income

-$317M

EPS (Diluted)

$-3.37

Cash Flow

Operating Cash Flow

-$292M

Free Cash Flow

-$295M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$691M

Total Liabilities

$61M

Stockholders' Equity

$630M

Cash & Equivalents

$435M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$2M	+8.9%
Operating Income	-$344M	-$242M	-42.0%
Net Income	-$317M	-$236M	-34.5%